Cargando…
Patient-reported treatment burden of chronic immune thrombocytopenia therapies
BACKGROUND: Chronic immune thrombocytopenia (ITP) is a debilitating autoimmune disorder that causes a reduction in blood platelets and increased risk of bleeding. ITP is currently managed with various pharmacologic therapies and splenectomy. This study was conducted to assess patient perceived and r...
Autores principales: | Brown, T Michelle, Horblyuk, Ruslan V, Grotzinger, Kelly M, Matzdorff, Axel C, Pashos, Chris L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350461/ https://www.ncbi.nlm.nih.gov/pubmed/22436142 http://dx.doi.org/10.1186/1471-2326-12-2 |
Ejemplares similares
-
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP
por: Georgi, Julia-Annabell, et al.
Publicado: (2023) -
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019) -
Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
por: Khelif, Abderrahim, et al.
Publicado: (2018) -
AZD-1222/tozinameran: Immune thrombocytopenia and exacerbation of pre-existing chronic immune thrombocytopenia: 4 case reports
Publicado: (2022) -
Acute on Chronic Immune Thrombocytopenia as a Cause of Thrombocytopenia in Sepsis
por: Kudaravalli, Pujitha, et al.
Publicado: (2020)